Cited by 15Urticaria and Related ConditionsChronic Disease Management StrategiesClinical practice guidelines implementation

Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany

Open access
Maurer, Marcus, Augustin, Matthias, Bauer, Sabine, Ekanayake‐Bohlig, Swarna, Kircher, Philipp, Knöll, Anja, Kramps, Thomas, Kurzen, Hjalmar +17 more·2024·Journal of the European Academy of Dermatology and Venereology

Abstract

Background: Chronic spontaneous urticaria (CSU) is both physically and emotionally stressful, and guideline recommendations are often not optimally implemented in clinical practice. The objective of this study was to provide an overview on the patient journey in CSU and to develop a mathematical model based on solid data. Methods: The journey of CSU patients in Germany was traced through literature review and expert meetings that included medical experts, pharmacists and representatives of patient organizations. The current situation's main challenges in the patient journey (education, collaboration and disease management) were discussed in depth. Then, a probabilistic model was developed in a co‐creation approach to simulate the impact of three potential improvement strategies: (1) patient education campaign, (2) medical professional education programme and (3) implementation of a disease management programme (DMP). Results: Chronic spontaneous urticaria patients are severely burdened by delays in diagnosis and optimal medical care. Our simulation indicates that in Germany, it takes on average of 3.8 years for patients to achieve disease control in Germany. Modelling all three optimization strategies resulted in a reduction to 2.5 years until CSU symptom control. On a population level, the proportion of CSU patients with disease control increased from 44.2% to 58.1%. Conclusions: In principle, effective CSU medications and a disease‐specific guideline are available. However, implementation of recommendations is lagging in practice. The approach of quantitative modelling of the patient journey validates obstacles and shows a clear effect of multiple interventions on the patient journey. The data generated by our simulation can be used to identify strategies for improving patient care. Our approach might helping in understanding and improving the management of patients beyond CSU.

Integrity signals

Registry

Crossref · 10.1111/jdv.19940

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maurer, M., Augustin, M., Bauer, S., Ekanayake‐Bohlig, S., Kircher, P., Knöll, A., Kramps, T., Kurzen, H., Laemmel, S., Novak, N., Oppel, E., Pirouzmandi, L., Rebhan, M., Reimnitz, U., Richter‐Huhn, G., Schwarz, B., Schwichtenberg, U., Staubach, P., Termeer, C., Thielen, A., Varga, K., von Bubnoff, D., Zink, A., Gmeiner, B., & Nathan, P.
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Urtikaria‐Helden, gUG Koblenz Germany
  • MENSINGDERMA Research Hamburg Germany
  • St. Ulrich‐Apotheke Peißenberg Germany
  • Hautarztpraxis Falkensee Germany
  • Novartis (Germany) (DE)
  • Haut‐ und Laerzentrum Freising Freising Germany
  • Deutscher Allergie‐ und Asthmabund e.V. – DAAB Berlin Germany
  • University Hospital Bonn (DE)
  • LMU Klinikum (DE)
  • Praxis Nettlingen Sölde Germany
  • Novartis (Switzerland) (CH)
  • Praxis Schwerin Schwerin Germany
  • Hautarztpraxis Dresden Dresden Germany
  • Haut- und Lasercentrum Potsdam (DE)
  • Derma‐Nord Hautarztpraxis Bremen Bremen Germany
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • University of Freiburg (DE)
  • Praxis Seifhennersdorf Seifhennersdorf Germany
  • Department Dermatology, Allergology and Venereology University Medical Center Lübeck Lübeck Germany
  • Karolinska Institutet (SE)
Corresponding author
Maurer, Marcus
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2024-03-05
Volume
38
Issue
11
Pages
2093-2101
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W4392458492
Cited by
15
References
4
Citations by year
2026: 7 · 2025: 7 · 2024: 1
FWCI
4.86
Type
journal article
Language
en
Open access
Locations
  • Journal of the European Academy of Dermatology and Venereology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by-nc)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • The Novartis Repository (Novartis) (submittedVersion)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
Funders
Novartis Pharma
Topics
  • Health Sciences › Medicine › Rheumatology › Urticaria and Related Conditions
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
chronic spontaneous urticaria, patient journey, disease management programs, patient education, medical education, guideline implementation, disease control, delayed diagnosis, co-creation, patient burden, Germany
MeSH terms
Chronic Urticaria, Female, Germany, Humans, Models, Theoretical, Patient Education as Topic, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review